Oren Elmaliah
Fortuna: 20 150 $ al 31/05/2026
Fortuna: 20 150 $ al 31/05/2026
Oren Elmaliah currently works at Presstek LLC, as Chief Financial Officer-Israel from 2017, Enlivex Therapeutics Ltd., as Controller from 2017, and My Size, Inc., as Chief Financial Officer from 2025.
Mr. Elmaliah also formerly worked at My Size, Inc., as Independent Director from 2017 to 2025 and Bioblast Pharma Ltd., as Chief Financial Officer & Controller.
Mr. Elmaliah received his undergraduate degree in 2011 from Tel-Aviv University and graduate degree in 2016 from Tel-Aviv University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
MY SIZE, INC. 0,67 % | 21/05/2026 | 32.500 ( 0,67 % ) | 20 150 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| MY SIZE, INC. | Director Financiero/CFO | 01/04/2025 |
Presstek LLC
Presstek LLC Industrial MachineryProducer Manufacturing Manufactures and supplies printing equipment & plates | Corporate Officer/Principal | 01/01/2017 |
Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd. BiotechnologyHealth Technology Develops autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions | Comptroller/Controller/Auditor | 01/02/2017 |
| Empresas | Cargo | Fin |
|---|---|---|
| MY SIZE, INC. | Director/Miembro de la Junta | 06/03/2025 |
| ENLIVEX LTD. | Director Financiero/CFO | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
Presstek LLC
Presstek LLC Industrial MachineryProducer Manufacturing Manufactures and supplies printing equipment & plates | Producer Manufacturing |
Bioblast Pharma Ltd.
Bioblast Pharma Ltd. BiotechnologyHealth Technology Operates as a biopharmaceutical company | Health Technology |
Tel-Aviv University
Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
My Size, Inc.
My Size, Inc. Internet Software/ServicesTechnology Services Engages in the development of smart phone application | Technology Services |
Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd. BiotechnologyHealth Technology Develops autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.